The relationship of cigarette smoking to end-stage renal disease

Seminars in Nephrology

Volumn 23, Issue 3, 2003, Pages 317-322

  Wesson, Donald E ^a,b  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC KIDNEY FAILURE; CIGARETTE SMOKING; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; GLOMERULONEPHRITIS; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FAILURE; KIDNEY PLASMA FLOW; KIDNEY VASCULAR RESISTANCE; MICROALBUMINURIA; OXIDATIVE STRESS; PRIORITY JOURNAL; RENAL ARTERY; RENOVASCULAR HYPERTENSION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SMOKING CESSATION; SYMPATHETIC TONE; VASCULAR DISEASE;

EID: 0037819363     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0270-9295(03)00037-8     Document Type: Article

References (83)

1. Orth SR: Smoking and the kidney. J Am Soc Nephrol 13:1663-1672, 2002
2. US: Renal Data System: USRDS 2000 Annual Data Report: Bethesda, MD, The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2002
3. Epstein M, Parving HH, Ruilope LM: Surrogate endpoints and renal protection: Focus on microalbuminuria. Blood Press Suppl 2:52-57, 1997
4. Bennett PH, Haffner S, Kasiske BL, et al: Screening and management of microalbuminuria in patients with diabetes mellitus: Recommendations to the Scientific Advisory Board of the National Kidney Foundation from an Ad Hoc Committee of the Council on Diabetes Mellitus of the National Kidney Foundation. Am J Kidney Dis 25:107-112, 1995
5. Gambaro G, Verlato F, Budakovic A, et al: Renal impairment in chronic cigarette smokers. J Am Soc Nephrol 9:562-567, 1998
6. Black HR, Zeevi GR, Silten RM, et al: Effect of heavy cigarette smoking on renal and myocardial arterioles. Nephron 34:173-179, 1983
7. Oberai B, Adams CWM, High OB: Myocardial and renal arteriolar thickening in cigarette smoking. Atherosclerosis 52:185-190, 1984
8. Ritz E, Benck U, Franek E, et al: Effects of smoking on renal hemodynamics in healthy volunteers and in patients with glomerular disease. J Am Soc Nephrol 9:1798-1804, 1998
9. Blann AD, McCollum CN: Adverse influence of cigarette smoking on the endothelium. Thromb Haemost 70:707-711, 1993
10. Klag MJ, Whelton PK, Randall BL, et al: Blood pressure and end-stage renal disease in men. N Engl J Med 334:13-18, 1996
11. Whelton PK, Randall B, Neaton J, et al: Cigarette smoking and ESRD incidence in men screened for MRFIT. J Am Soc Nephrol 6:408A, 1995
12. Goetz FC, Jacobs DRJ, Chavers B, et al: Risk factors for kidney damage in the adult population of Wadena, Minnesota: A prospective study. Am J Epidemiol 145:91-102, 1997
13. Baffio B, Budakovic A, Gambaro G: Cardiovascular risk factors, smoking, and kidney function. Nephrol Dial Transplant 13:2-5, 1998 (suppl 7)
14. Metcalf PA, Baker JR, Scragg RK, et al: Albuminuria in people at least 40 years old: Effect of alcohol consumption, regular exercise, and cigarette smoking. Clin Chem 39:1793-1797, 1993
15. Cirillo M, Senigalliesi L, Larenzi M, et al: Microalbuminuria in nondiabetic adults: Relation of blood pressure, body mass index, plasma cholesterol levels, and smoking. The Gubbio Population Study. Arch Intern Med 158:1933-1939, 1998
16. Pinto-Sietsma S, Mulder J, Janssen W, et al: Smoking is related to albuminuria and abnormal renal function in nondiabetic persons. Ann Intern Med 133:585-591, 2000
17. Christiansen JS: Cigarette smoking and the prevalence of microangiopathy in juvenile-onset insulin-dependent diabetes mellitus. Diabetes Care 1:146-149, 1978
18. Telmer S, Christiansen JS, Andersen AR, et al: Smoking habits and prevalence of clinical diabetic microangiopathy in insulin-dependent diabetics. Acta Med Scand 215:63-68, 1984
19. Chase HP, Garg SK, Marshall G, et al: Cigarette smoking increases the risk of albuminuria among subjects with type I diabetes. JAMA 265:614-617, 1991
20. Microalbuminuria Collaborative Study Group, United Kingdom: Risk factors for development of microalbuminuria in insulin dependent diabetic patients: A cohort study. BMJ 306:1235-1239, 1993
21. Corradi L, Zoppi A, Tettamanti F, et al: Association between smoking and microalbuminuria in hypertensive patients with type 2 diabetes mellitus. J Hypertens Suppl 11:S190-S191, 1993
22. Savage S, Nagel NJ, Estacio RO, et al: Clinical factors associated with urinary albumin excretion in type II diabetes. Am J Kidney Dis 25:836-844, 1995
23. Sawicki PT, Didjurgeit U, Muhlhauser I, et al: Smoking is associated with progression of diabetic nephropathy. Diabetes Care 17:126-131, 1994
24. Muhlhauser I, Sawicki P, Berger M: Cigarette-smoking as a risk factor for macroproteinuria and proliferative retinopathy in type 1 (insulin-dependent) diabetes. Diabetologia 29:500-502, 1986
25. Yokoyama H, Tomonaga O, Hirayama M, et al: Predictors of the progression of diabetic nephropathy and the beneficial effect of angiotensin converting enzyme inhibitors in NIDDM patients. Diabetologia 40:405-411, 1997
26. Chuahirun T, Wesson DE: Cigarette smoking predicts faster progression of type 2 established diabetic nephropathy despite angiotensin converting enzyme inhibition. Am J Kidney Dis 39:376-382, 2002
27. Chuahirun T, Simoni J, Hudson C, et al: Smoking cessation compared with continued smoking ameliorates albuminuria in type 2 diabetes. J Am Soc Nephrol 13:248A, 2002
28. Sawicki PT, Didjurgeit U, Muhlhauser I, et al: Smoking is associated with progression of diabetic nephropathy. Diabetes Care 17:126-131, 1994
29. Biesenbach G, Janko O, Zazgornik J: Similar rate of progression in the predialysis phase in type 1 and type 2 diabetes mellitus. Nephrol Dial Transplant 9:1097-1102, 1994
30. Biesenbach G, Grafinger P, Janko O, et al: Influence of cigarette-smoking on the progression of clinical diabetic nephropathy in type 2 diabetic patients. Clin Nephrol 48:146-150, 1997
31. Chuahirun T, Khanna A, Kimball K, et al: Cigarette smoking and increased urine albumin excretion are interrelated predictors of nephropathy progression in type 2 diabetes. Am J Kidney Dis 41:13-21, 2003
32. Mimram A, Ribstein J, DuCailar G, et al: Albuminuria in normals and essential hypertension. J Diab Complications 8:150-156, 1994
33. Horner D, Iliser D, Klimm HP, et al: Albuminuria in normotensive and hypertensive individuals attending offices of general practitioners. J Hypertens 14:665-660, 1996
34. Gerstein HC, Mann JF, Pogue J, et al: Prevalence and determinants of microalbuminuria in high-risk diabetic and non-diabetic patients in the Heart Outcomes Prevention Evaluation Study. The HOPE Study Investigators. Diabetes Care 23:B35-B39, 2000 (suppl 2)
35. Watchtell K, Olsen MH, Dahlof B, et al: Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE Study. J Hypertens 20:405-412, 2002
36. Regalado M, Yang S, Wesson DE: Cigarette smoking is associated with augmented progression of renal insufficiency in severe essential hypertension. Am J Kidney Dis 35:687-694, 2000
37. Yaqoob M, Bell GM, Percy DF, et al: Primary glomerulonephritis and hydrocarbon exposure: A case-control study and literature review. QJM 83:409-418, 1992
38. Merkel F, Pullig O, Marx M, et al: Course and prognosis of anti-basement membrane antibody (anti-BM-Ab)-mediated disease: Report of 35 cases. Nephrol Dial Transplant 9:372-376, 1994
39. Wakai K, Kawamura T, Matsuo S, et al: Risk factors for IgA nephropathy: A case-control study in Japan. Am J Kidney Dis 33:738-745, 1999
40. Hogan SL, Satterly KK, Dooley MA, et al: Silica exposure in anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and lupus nephritis. J Am Soc Nephrol 12:134-142, 2001
41. Samuelsson O, Attman PO: Is smoking a risk factor for progression of chronic renal failure? Kidney Int 58:2597[Letter], 2000
42. Ward MM, Studenski S: Clinical prognostic factors in lupus nephritis. The importance of hypertension and smoking. Arch Intern Med 152:2082-2088, 1992
43. Font J, Ramo-Casals M, Cervera R, et al: Cardiovascular risk factors and the long-term outcome of lupus nephritis. QJM 94:19-26, 2001
44. Chapman AM, Johnson AM, Gabow PA, et al: Overt proteinuria and microalbuminuria in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 5:1349-1354, 1994
45. Orth SR, Stockmann A, Conradt C, et al: Smoking as a risk factor for end-stage renal failure 1 men with primary renal disease. Kidney Int 54:926-931, 1998
46. Parving H-H, Andersen AR, Smidt UM, et al: Early aggressive anti-hypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet 1:1175-1179, 1983
47. Toto RD, Mitchell HC, Smith RD, et al: "Strict" blood pressure control and progression of renal disease in hypertensive nephrosclerosis. Kidney Int 48:851-859, 1995
48. Groppelli A, Giogi DMA, OmBoni S, et al: Persistent blood pressure increase induced by heavy smoking. J Hypertens 10:495-499, 1992
49. Mann SJ, James GD, Wang RS, et al: Elevation of ambulatory systolic blood pressure in hypertensive smokers: A case control study. JAMA 265:2226-2228, 1991
50. McNagny SE, Ahluwalia JS, Clark WS, et al: Cigarette smoking and severe uncontrolled hypertension in inner-city African Americans. Am J Med 103:121-127, 1997
51. Narkiewicz K, ban de Boren PJ, Hausberg M, et al: Cigarette smoking increases sympathetic outflow in humans. Circulation 98:528-534, 1998
52. Fogo A, Breyer JA, Smith MC, et al: Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: A report from the African American Study of Kidney Disease (AASK) Trial. AASK Pilot Study Investigators: Kidney Int 51:244-252, 1997
53. Meyrier A, Hill GS, Simon P: Ischemic renal diseases: New insights into old entities. Kidney Int 54:2-13, 1998
54. Lhotta K, Rumpelt HJ, Konig P, et al: Cigarette smoking and vascular pathology in renal biopsies. Kidney Int 61:648-654, 2002
55. Ritz E, Benck U, Franek E, et al: Effects of smoking on renal hemodynamics in healthy volunteers and in patients with glomerular disease. J Am Soc Nephrol 9:1798-1804, 1998
56. Blann AD, McCollum CN: Adverse influence of cigarette smoking on the endothelium. Thromb Haemost 70:707-711, 1993
57. Alcazar JM, Marin R, Gomez-Campdera F, et al: Clinical characteristics of ischaemic renal disease. Nephrol Dial Transplant 16:74-7, 2001 (suppl 1)
58. Gambaro G, Bertaglia G, Citron L, et al: Effects of cigarette smoking on the kidney. Contrib Nephrol 130:39-44, 2000
59. Bofinger A, Hawley C, Fisher P, et al: Increased severity of multifocal renal arterial fibromuscular dysplasia in smokers. J Hum Hypertens 13:517-520, 1999
60. Orth S, Ritz E: The renal risks of smoking: An update. Curr Opin Nephrol Hypertens 11:483-488, 2002
61. Tracy RE, Strong JP, Newman WPI, et al: Renovasculopathies of nephrosclerosis in relation to atherosclerosis at age 25-54 years. Kidney Int 49:564-570, 1996
62. Tracy RE: Histologic characteristics of coronary artery in relation to renovasculopathies of hypertension. Ann Diagn Pathol 2:159-166, 1998
63. Diamond JR: Analogous pathobiologic mechanisms in glomerulosclerosis and atherosclerosis. Kidney Int 39:S29-S34, 1991 (suppl 31)
64. Esmatjes E, Flores L, Lario S, et al: Smoking increases serum levels of transforming growth factor-beta in diabetic patients [Letter]. Diabetes Care 22:1915-1916, 1999
65. Haak T, Jungmann E, Raab C, et al: Elevated endothelin-1 levels after cigarette smoking. Metabolism 43:267-269, 1994
66. Ziyadeh FN, Hoffman BB, Han DC, et al: Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db mice. Proc Natl Acad Sci U S A 97:8015-8020, 2000
67. Chen H-C, Guh J-Y, Shin S-J, et al: Reactive oxygen species enhances endothelin-1 production of diabetic rat glomeruli in vitro and in vivo. J Lab Clin Med 135:309-315, 2000
68. Tharaux P-L, Chatziantoniou C, Casellas D, et al: Vascular endothelin-1 gene expression and synthesis and effect on renal type 1 collagen synthesis and nephroangiosclerosis during nitric oxide synthase inhibition in rats. Circulation 99:2185-2191, 1999
69. Rizvi MA, Katwa L, Spadone DP, et al: The effects of endothelin-1 on collagen type I and type III synthesis in cultured porcine coronary artery vascular smooth muscle cells. J Mol Cell Cardiol 28:243-252, 1996
70. Massagne J: The transforming growth factor family. Ann Rev Cell Dev Biol 6:597-641, 1990
71. August P, Leventhal B, Suthanthiran M: Hypertension-induced organ damage in African Americans: Transforming growth factor β1 excess as a mechanism for increased prevalence. Curr Hypertens Reports 2:184-191, 2000
72. Gilbert RE, Cooper ME: The tubulointerstitium in progressive diabetic kidney disease: More than an aftermath of glomerular injury? Kidney Int 56:1627-1637, 1999
73. Kanauchi M, Dohi K: Predictors of diabetic renal lesions in type 2 diabetes associated with microalbuminuria. Eur J Clin Invest 31:110-112, 2001
74. Tracy RE, Berenson G, Wattigney W, et al: The evolution of benign arterionephrosclerosis from age 6 to 70 years. Am J Pathol 136:429-439, 1990
75. Obata T, Tomaru K, Nagakura T, et al: Smoking and oxidant stress: Assay of isoprostane in human urine by gas chromatography-mass spectrometry. J Chromatogr Biomed Sci Appl 746:11-15, 2000
76. Melhem MF, Craven PA, Derubertis FR: Effects of dietary supplementation of α-lipoic acid on early glomerular injury in diabetes mellitus. J Am Soc Nephrol 12:124-133, 2001
77. Landmesser U, Harrison DG: Oxidative stress and vascular damage in hypertension. Coron Artery Dis 12:455-461, 2001
78. Cominacini L, Garbin U, Pastorino AM, et al: Increased susceptibility of LDL to in vitro oxidation in patients with IDDM and NIDDM. Diabetes Res 26:173-184, 1994
79. Skyrme-Jones RAP, O'Brien RC, Berry KL, et al: Vitamin E supplementation improves endothelial function in type 1 diabetes mellitus: A randomized, placebo-controlled study. J Am Coll Cardiol 36:94-102. 2000
80. Hasdan G, Benchetrit S, Rashid G, et al: Endothelial dysfunction and hypertension in 5/6 nephrectomized rats are mediated by vascular superoxide. Kidney Int 61:586-590, 2002
81. Ligtenberg G, Blankestijn PJ, Oey PL, et al: Reduction of sympathetic overactivity by enalapril in patients with chronic renal failure. N Engl J Med 340:1321-1328, 1999
82. Ottesen MM, Worck R, Ibsen H: Captopril does not blunt the sympathoadrenal response to cigarette smoking in normotensive humans. Blood Press 6:29-34, 1997
83. Amann K, Rump LC, Simonavicience A, et al: Effects of low dose sympathetic inhibition on glomerulosclerosis and albuminuria in subtotally nephrectomized rats. J Am Soc Nephrol 11:1469-1478, 2000